Journal of Clinical Toxicology
Open Access

Department of Gastroenterology, School of Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA

Biography

Dr. Kevin Murnane's research group is focused on the etiology, consequences, and treatment of disorders of the central nervous system. His research lab has the most well developed interests in the study of drug addiction and Alzheimer's disease. To develop new treatments for these disorders, the Murnane group uses techniques such as behavioral pharmacology, operant conditioning, neuroimaging, in vivo microdialysis, computational chemistry, analytical chemistry, drug formulation, physiology, electroencephalography, and immunohistochemistry.

Publications

• Case Report   
  An Unusual Case Report of Fatal Oral Ingestion of the Emerging “Bath Salt” Eutylone
  Author(s): Steven Fleming, Nicholas E. Goeders*, James C. Patterson II, Kenneth J. Manas and Kevin S. Murnane
  
  Background: The abuse of novel psychoactive substances, such as synthetic stimulants, is increasing each year with modifications to drug scaffolds to alter pharmacokinetics or pharmacodynamics. Psychosis, cardiotoxicity, and excited delirium have been documented with intense sympathomimetic stimulants. The clinical recognition of these substances is challenging as routine blood and urine drug screening protocols do not readily detect the presence of these synthetic substances. We report an unusual case of oral ingestion of eutylone with subsequent confirmation of this substance. Case details: A 49-year old female with history of chronic cardiovascular comorbidities, type 2 diabetes, depression, and end stage renal disease was presented to Emergency Department with 2-3 week history of abdominal distention with melenic stools. She was found to.. View More»
  DOI: 10.35248/2161-0495.21.s18.003

  Abstract HTML PDF